Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

NCT03200626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2023-03-28

No results posted yet for this study

Summary

Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.

Conditions

Interventions

PROCEDURE

Autologous hematopoietic cell transplant

Autologous hematopoietic cell transplant

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    collaborator INDUSTRY
  • Medical College of Wisconsin

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2021-09-29
Completion
2022-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03200626 on ClinicalTrials.gov